Showing 1,141 - 1,160 results of 4,368 for search '(( significant decrease decrease ) OR ( significant clinical decrease ))~', query time: 0.23s Refine Results
  1. 1141

    Eligibility criteria. by Keean Nanji (16516622)

    Published 2024
    “…Data will be collected and synthesized for seven pre-specified outcomes at 6 weeks and 3 months following surgery: i) change in central retinal thickness measured by optical coherence tomography (OCT), ii) best-recorded visual acuity iii) the rate of CME measured by OCT, and fluorescein angiography (FA) iv) the rate of patients experiencing clinically significant macular edema defined as the presence of CME and pre-specified thresholds for decreased visual acuity, v) patient quality of life, vi) intraocular pressure and vii) the number of patients experiencing one or more pre-specified adverse events. …”
  2. 1142

    Flowchart of the clinical trial. by Shenghang Wang (21213000)

    Published 2025
    “…The clinical trial’s results showed that MMF treatment had a positive effect on the improvement of BMD in the lumbar spine and increased serum P1NP levels while decreased β-CTX levels. …”
  3. 1143

    Plant Extracellular Nanovesicle-Loaded Hydrogel for Topical Antibacterial Wound Healing <i>In Vivo</i> by Saroj Saroj (13749336)

    Published 2024
    “…Bacterial infections impede wound healing and pose significant challenges in clinical care. There is an immediate need for safe and targeted antivirulence agents to fight bacterial infections effectively. …”
  4. 1144

    Plant Extracellular Nanovesicle-Loaded Hydrogel for Topical Antibacterial Wound Healing <i>In Vivo</i> by Saroj Saroj (13749336)

    Published 2024
    “…Bacterial infections impede wound healing and pose significant challenges in clinical care. There is an immediate need for safe and targeted antivirulence agents to fight bacterial infections effectively. …”
  5. 1145

    Trend of total hospital attendance. by Yaw Nyarko Opoku-Boateng (20477302)

    Published 2024
    “…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
  6. 1146

    Trend of outpatient (OPD) consultations. by Yaw Nyarko Opoku-Boateng (20477302)

    Published 2024
    “…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
  7. 1147

    Variables used for the analysis. by Yaw Nyarko Opoku-Boateng (20477302)

    Published 2024
    “…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
  8. 1148

    Trend of PNC attendance over the period. by Yaw Nyarko Opoku-Boateng (20477302)

    Published 2024
    “…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
  9. 1149

    Trend of ANC attendance over the period. by Yaw Nyarko Opoku-Boateng (20477302)

    Published 2024
    “…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
  10. 1150

    Total hospital attendances by specialty. by Yaw Nyarko Opoku-Boateng (20477302)

    Published 2024
    “…Month-on-month, antenatal and out-patient utilization decreased by 21,948.21 and 151,342.40, respectively. …”
  11. 1151
  12. 1152

    Baseline characteristics of the study sample<sup>β</sup>μ. by Osama Mohamed Ibrahim (12006954)

    Published 2024
    “…<div><p>Background</p><p>Drug-related problems (DRPs) significantly threaten the safety of the elderly. In order to improve pharmacists’ ability to minimize these events, novel educational interventions that consider the current challenges in clinical practice are crucial.…”
  13. 1153

    The flow diagram of the study (CONSORT, 2010). by Osama Mohamed Ibrahim (12006954)

    Published 2024
    “…<div><p>Background</p><p>Drug-related problems (DRPs) significantly threaten the safety of the elderly. In order to improve pharmacists’ ability to minimize these events, novel educational interventions that consider the current challenges in clinical practice are crucial.…”
  14. 1154

    Forest plot for clinical efficacy. by Xuqin Du (8803772)

    Published 2025
    “…</p><p>Conclusion</p><p>The current evidence suggests that QJHTD, as an adjunct therapy to standard treatment, may significantly improve pulmonary function, reduce inflammatory mediators, and enhance clinical efficacy in patients with stable COPD, with a favorable safety profile. …”
  15. 1155
  16. 1156
  17. 1157

    Data analysed during this study. by Jakkrit Juhong (20968015)

    Published 2025
    “…In contrast, beta diversity analysis, assessed through Bray-Curtis dissimilarity, revealed significant differences in microbial composition between pre- and post-treatment samples. …”
  18. 1158

    Baseline analysis, nominal factors. by Hiroaki Yoshikawa (4615801)

    Published 2025
    “…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”
  19. 1159

    Minimal dataset for the study. by Hiroaki Yoshikawa (4615801)

    Published 2025
    “…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”
  20. 1160

    Baseline analysis, continuous factors. by Hiroaki Yoshikawa (4615801)

    Published 2025
    “…Regarding treatment, the utilization of tacrolimus, plasma exchange (PE), and intravenous immunoglobulin (IVIg) significantly increased between 2006 and 2018. In contrast, the rates of thymectomy and both maximum and current oral steroid dosages decreased during this period.…”